相关实验视频
Updated: Sep 19, 2025

02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
529
对海利-海利病的治疗算法建议
Nefeli Giannopoulou1, Olivia Mathot1, Bertrand Richert1
1Dermatology Department, Université Libre de Bruxelles, University Hospital Brugmann and Saint-Pierre, Brussels, Belgium.
Journal of cutaneous medicine and surgery
|June 16, 2025
概括
海利-海利病是一种罕见的遗传性皮肤疾病,由于治疗选择有限,它带来了挑战. 本综述系统地分析了当前和新兴疗法,以指导这种慢性疾病的临床决策.
科学领域:
- 皮肤病学 皮肤病学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 海利-海利病是一种罕见的自体主导性基因皮肤病,影响质细胞粘附.
- 它是由ATP2C1基因突变引起的,临床表现为,侵蚀和曲区域的裂.
- 这种情况遵循慢性复发过程,治疗选择有限.
研究的目的:
- 系统地审查海利-海利病的既定和新兴治疗方法.
- 评估支持各种治疗方案的证据.
- 为临床决策提出治疗算法.
主要方法:
- 对海利-海利病治疗方法的系统文献分析.
- 对每种治疗方式的证据强度的评估.
- 专注于药理疗法和程序疗法.
主要成果:
- 有广泛的治疗方法,包括局部,全身和手术选择.
- 治疗有效性和安全性的证据往往是有限的,因为缺乏大型试验.
- 非药物治疗措施对于控制疾病至关重要.
结论:
- 为海利-海利病制定基于证据的指导方针是一项挑战.
- 需要对治疗证据的全面理解,以指导临床实践.
- 本综述旨在提供一种结构化的方法来管理海利-海利病.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
67
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
67
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28

